ES2779990T3 - Reducción de la motilidad de células cancerosas utilizando campos de tratamiento de tumores (TTFIELDS) - Google Patents

Reducción de la motilidad de células cancerosas utilizando campos de tratamiento de tumores (TTFIELDS) Download PDF

Info

Publication number
ES2779990T3
ES2779990T3 ES17716642T ES17716642T ES2779990T3 ES 2779990 T3 ES2779990 T3 ES 2779990T3 ES 17716642 T ES17716642 T ES 17716642T ES 17716642 T ES17716642 T ES 17716642T ES 2779990 T3 ES2779990 T3 ES 2779990T3
Authority
ES
Spain
Prior art keywords
frequency
amplitude
electric field
signal
target region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17716642T
Other languages
English (en)
Spanish (es)
Inventor
Rosa Shnaiderman
Moshe Giladi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novocure GmbH
Original Assignee
Novocure GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novocure GmbH filed Critical Novocure GmbH
Application granted granted Critical
Publication of ES2779990T3 publication Critical patent/ES2779990T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G05—CONTROLLING; REGULATING
    • G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B19/00—Program-control systems
    • G05B19/02—Program-control systems electric
    • G05B19/04—Program control other than numerical control, i.e. in sequence controllers or logic controllers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36002—Cancer treatment, e.g. tumour
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Automation & Control Theory (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES17716642T 2016-04-04 2017-04-04 Reducción de la motilidad de células cancerosas utilizando campos de tratamiento de tumores (TTFIELDS) Active ES2779990T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662317985P 2016-04-04 2016-04-04
PCT/IB2017/051898 WO2017175116A1 (en) 2016-04-04 2017-04-04 Reducing motility of cancer cells using tumor treating fields (ttfields)

Publications (1)

Publication Number Publication Date
ES2779990T3 true ES2779990T3 (es) 2020-08-21

Family

ID=58530601

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17716642T Active ES2779990T3 (es) 2016-04-04 2017-04-04 Reducción de la motilidad de células cancerosas utilizando campos de tratamiento de tumores (TTFIELDS)

Country Status (11)

Country Link
US (2) US10821283B2 (enExample)
EP (3) EP4234005B1 (enExample)
JP (2) JP6896839B2 (enExample)
KR (1) KR102430229B1 (enExample)
CN (2) CN109475735B (enExample)
DK (1) DK3439733T3 (enExample)
ES (1) ES2779990T3 (enExample)
HU (1) HUE048646T2 (enExample)
PL (1) PL3439733T3 (enExample)
PT (1) PT3439733T (enExample)
WO (1) WO2017175116A1 (enExample)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10779875B2 (en) 2013-05-06 2020-09-22 Novocure Gmbh Optimizing treatment using TTfields by changing the frequency during the course of long term tumor treatment
US10188851B2 (en) 2015-10-28 2019-01-29 Novocure Limited TTField treatment with optimization of electrode positions on the head based on MRI-based conductivity measurements
US10821283B2 (en) 2016-04-04 2020-11-03 Novocure Gmbh Reducing motility of cancer cells using tumor treating fields (TTFields)
DK3474760T3 (da) 2016-06-27 2023-03-20 Galvanize Therapeutics Inc Generator og et kateter med en elektrode til at behandle en lungepassage
US12403305B2 (en) 2016-06-27 2025-09-02 Galvanize Therapeutics, Inc. Immunostimulation in the treatment of viral infection
EP3478360B1 (en) 2016-06-30 2024-04-10 Novocure GmbH Arrays for longitudinal delivery of ttfields to a body
EP3571503B1 (en) 2017-01-19 2026-04-15 Novocure GmbH System for viewing cell cultures under a microscope whilst applying ttfields
US12649056B2 (en) * 2017-10-23 2026-06-09 Cardiac Pacemakers, Inc. Medical devices for treatment of cancer with electric fields
US11338135B2 (en) 2017-10-23 2022-05-24 Cardiac Pacemakers, Inc. Medical devices for cancer therapy with electric field shaping elements
US12403306B2 (en) * 2017-10-23 2025-09-02 Cardiac Pacemakers, Inc. Electric field shaping leads for treatment of cancer
US20200368525A1 (en) * 2017-11-17 2020-11-26 Abbvie Inc. Methods of Treating Glioblastoma
EP4552592A3 (en) 2017-12-26 2025-06-18 Galvanize Therapeutics, Inc. Optimization of energy delivery for various applications
US10953209B2 (en) 2018-03-28 2021-03-23 Board Of Regents Of The University Of Texas System Treating tumors using TTFields combined with a PARP inhibitor
CN112566665A (zh) 2018-04-09 2021-03-26 莫舍·吉拉迪 用TTFields和Aurora激酶抑制剂治疗肿瘤
US11650277B2 (en) 2018-04-10 2023-05-16 Novocure Gmbh TTField treatment with optimization of electrode positions based on low frequency (<1MHZ) AC conductivity estimates derived from two MRI images having different repetition times
KR102870236B1 (ko) * 2018-07-03 2025-10-14 에드윈 창 세포막 투과성을 향상시키기 위한 교류 전기장 사용
NZ770868A (en) * 2018-07-10 2023-12-22 Novocure Gmbh Inhibiting viral infection using alternating electric fields
US11179322B2 (en) 2018-07-10 2021-11-23 Novocure Gmbh Methods and compositions for treating tumors with TTFields and sorafenib
IL279253B2 (en) 2018-07-18 2025-09-01 Novocure Gmbh Using power loss density and related measurements to quantify dose of tumor treatment fields
MX2020013519A (es) * 2018-08-23 2021-05-12 Novocure Gmbh Uso de campos electricos alternativos para aumentar la permeabilidad de la barrera hematoencefalica.
US11623085B2 (en) 2018-08-29 2023-04-11 Regents Of The University Of Minnesota Devices and methods for treatment of tumors using electromagnetic signal
US11160977B2 (en) 2018-09-04 2021-11-02 Novocure Gmbh Delivering tumor treating fields (TTFields) to the infratentorial brain
US11020585B2 (en) 2018-09-07 2021-06-01 Novocure Gmbh Treating autoimmune diseases using an alternating electric field to reduce the proliferation of t-cells
US11986647B2 (en) 2018-09-07 2024-05-21 Novocure Gmbh Treating autoinflammatory and mitochondrial diseases using an alternating electric field
HUE061361T2 (hu) 2018-10-15 2023-06-28 Novocure Gmbh Az egész agyban nagy egyenletességû tumorkezelõ mezõk (TT-mezõk) generálása
CN112955208B (zh) 2018-10-25 2024-11-22 诺沃库勒有限责任公司 向受试者的脊柱解剖结构递送交变电场(例如，ttfields)的方法
US12186575B2 (en) 2018-11-13 2025-01-07 The Methodist Hospital Method and apparatus for oncomagnetic treatment
HUE065574T2 (hu) 2018-11-19 2024-06-28 Novocure Gmbh Tömbök daganatkezelõ mezõk (TTFIELD) rendelkezésre bocsátására szelektíven címezhetõ alelemekkel
JP7353363B2 (ja) 2018-11-29 2023-09-29 ノボキュア ゲーエムベーハー ＴＴＦｉｅｌｄｓ（腫瘍治療電場）を提供するための柔軟性を高めたトランスデューサーアレイ
EP3968279B1 (en) 2019-01-08 2025-01-01 Novocure GmbH Evaluating quality of segmentation of an image into different types of tissue for planning treatment using tumor treating fields (ttfields)
WO2020174403A1 (en) 2019-02-26 2020-09-03 Moshe Giladi Determining a frequency for ttfields treatment based on an electrical characteristic of targeted cancer cells
EP4491214B1 (en) 2019-02-27 2026-01-21 Novocure GmbH Delivering tumor treating fields (ttfields) using implantable transducer arrays
PL3946322T3 (pl) 2019-03-29 2024-02-26 Novocure Gmbh Sposoby przywracania wrażliwości na ttfields w komórkach nowotworowych opornych wobec ttfields, z inhibitorami ptger3
CN111803792A (zh) * 2019-04-12 2020-10-23 上海必修福企业管理有限公司 空间电场的发生装置
WO2020212824A1 (en) 2019-04-17 2020-10-22 Yoram Wasserman Uploading data from an isolated system without compromising isolation
CN114007535A (zh) 2019-04-18 2022-02-01 盖乐世公司 用于治疗异常组织的装置、系统和方法
CN113766949B (zh) * 2019-04-22 2025-04-08 波士顿科学国际有限公司 用于施用电刺激以治疗癌症的系统
JP7593942B2 (ja) 2019-04-22 2024-12-03 ボストン サイエンティフィック サイムド，インコーポレイテッド 癌治療のための電気刺激機器
US12109412B2 (en) 2019-04-22 2024-10-08 Boston Scientific Scimed, Inc. Combination electrical and chemotherapeutic treatment of cancer
US11607542B2 (en) 2019-04-23 2023-03-21 Boston Scientific Scimed, Inc. Electrical stimulation for cancer treatment with internal and external electrodes
JP2022529374A (ja) 2019-04-23 2022-06-21 ボストン サイエンティフィック サイムド，インコーポレイテッド がん治療のための電気刺激用電極
WO2020219521A1 (en) * 2019-04-23 2020-10-29 Boston Scientific Scimed, Inc. Electrical stimulation with thermal treatment or thermal monitoring
CA3147592A1 (en) 2019-07-16 2021-01-21 Galary, Inc. Treatment of the reproductive tract with pulsed electric fields
CN121314073A (zh) 2019-07-31 2026-01-13 诺沃库勒有限责任公司 经由埋入颅骨植入物中的电极施加肿瘤治疗场（TTField）
CN114390914A (zh) 2019-08-05 2022-04-22 诺沃库勒有限责任公司 通过抑制il11活性增加癌细胞对肿瘤治疗场(ttfield)的敏感性
US11890467B2 (en) 2019-08-30 2024-02-06 Novocure Gmbh Delivering tumor treating fields (TTFields) to the neck
US12458709B2 (en) * 2019-12-11 2025-11-04 Novocure Gmbh Compositions and methods for imaging a cell
JP7687698B2 (ja) * 2019-12-26 2025-06-03 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 癌細胞における異常な解糖的代謝を正常化する方法
HUE061733T2 (hu) 2019-12-31 2023-08-28 Novocure Gmbh Tömbök tumorkezelõ mezõk (TTFields) szállítására egyenként hozzáférhetõ elektródaelemekkel és hõmérsékletérzékelõkkel
US12121739B2 (en) 2019-12-31 2024-10-22 Novocure Gmbh Methods, systems, and apparatuses for managing temperatures induced by alternating fields
US20230147250A1 (en) * 2019-12-31 2023-05-11 Novocure Gmbh Methods, systems, and apparatuses for combined tumor treating fields and mental health therapy
KR20220122679A (ko) 2019-12-31 2022-09-02 노보큐어 게엠베하 채널들의 스위칭 및 진폭 조정 중 스파이크들을 방지하는 고전압, 고효율 사인파 생성기
US11883655B2 (en) 2020-02-24 2024-01-30 Boston Scientific Scimed, Inc. Systems and methods for treatment of pancreatic cancer
US20210299440A1 (en) 2020-03-30 2021-09-30 Novocure Gmbh Intravenous / Intra-Spinal / Intra-Cavity / Intraventricular Delivery of TTFields (Tumor Treating Fields) for Treating Cancer and Metastases
KR102644003B1 (ko) * 2020-04-01 2024-03-07 한국전자통신연구원 암 치료 장치
CN115348844A (zh) 2020-04-08 2022-11-15 盖能适治疗股份有限公司 脉冲电场波形操作和使用
CN115916325A (zh) * 2020-04-24 2023-04-04 诺沃库勒有限责任公司 使用交变电场增加血脑屏障的通透性
CN115443171A (zh) * 2020-05-08 2022-12-06 诺沃库勒有限责任公司 向多能干细胞施加交变电场的组合物和方法
KR102464313B1 (ko) 2020-05-18 2022-11-08 주식회사 필드큐어 전기장 암 치료 시스템을 위한 품질 보증 장치 및 방법
WO2021257967A1 (en) 2020-06-19 2021-12-23 The Methodist Hospital Dba Houston Methodist Hospital Method and apparatus for oncomagnetic treatment
US11818943B2 (en) 2020-06-25 2023-11-14 Novocure Gmbh Fabricating organic light emitting diodes (OLEDs) using tubulin
EP4567054B1 (en) * 2020-06-30 2025-12-17 Novocure GmbH Flexible transducer arrays with a polymer insulating layer for applying tumor treating fields (ttfields)
JP7886853B2 (ja) * 2020-09-18 2026-07-08 ノボキュア ゲーエムベーハー コロナウイルスを処置するための方法及び組成物
EP4223363B1 (en) 2020-09-25 2024-04-24 Novocure GmbH Varying the metallization area on individual electrode elements in a tumor treating fields system to maximize current without overheating
JP7145280B2 (ja) * 2020-10-13 2022-09-30 Ｔｖｓ Ｒｅｇｚａ株式会社 送受信方法
KR102519139B1 (ko) 2020-11-25 2023-04-25 주식회사 필드큐어 회전하는 교류 전기장을 이용한 전기장 인가 장치 및 방법
WO2022112945A1 (en) * 2020-11-25 2022-06-02 Novocure Gmbh Increasing the efficacy of tumor treating fields (ttfields) by applying the ttfields at peak intensity less than half the time
WO2022130183A2 (en) 2020-12-17 2022-06-23 Novocure Gmbh Pyroelectric-based temperature sensing of transducer arrays for applying tumor treating fields (ttfields)
CN116782980A (zh) 2020-12-21 2023-09-19 诺沃库勒有限责任公司 复合电极的优化
CN112553075A (zh) * 2020-12-28 2021-03-26 湖南安泰康成生物科技有限公司 一种用敏感频率电场抑制肿瘤细胞快速生长的方法及装置
CN117098577A (zh) * 2020-12-30 2023-11-21 诺沃库勒有限责任公司 用于肿瘤治疗场的调幅
WO2022147153A1 (en) * 2020-12-30 2022-07-07 Novocure Gmbh Amplitude modulation for tumor treating fields
IT202100000119A1 (it) * 2021-01-05 2022-07-05 Telea Electronic Eng Srl Dispositivo e farmaco antitumorale per il trattamento di cellule neoplastiche
US20220241603A1 (en) * 2021-02-03 2022-08-04 Novocure Gmbh Varying Parameters of Tumor Treating Fields (TTFields) Treatment to Overcome Treatment Resistance
EP4043071A1 (en) * 2021-02-12 2022-08-17 Scientia Biotech S.L. Non-invasive cancer treatment
JP7844490B2 (ja) 2021-02-17 2026-04-13 ノボキュア ゲーエムベーハー 個別に調節可能な活性領域を有する電極素子のセットで腫瘍治療電場（ＴＴＦｉｅｌｄｓ）を送達するためのアレイ
JP2024509964A (ja) 2021-03-12 2024-03-05 ノボキュア ゲーエムベーハー 交流電界を用いてマクロファージの表現型をスキューイングすることによる、疾患を処置する方法
WO2022200964A1 (en) * 2021-03-23 2022-09-29 Novocure Gmbh Transducer apparatuses for delivering tumor treating fields to a subject's body
CN117120139A (zh) 2021-03-31 2023-11-24 诺沃库勒有限责任公司 使用肿瘤治疗场（ttfield）系统的电极的阻抗断层摄影
WO2022215051A1 (en) 2021-04-08 2022-10-13 Novocure Gmbh Methods of treating neurodegenerative disorders with alternating electric fields
TWI905187B (zh) * 2021-05-11 2025-11-21 瑞士商諾萬可有限公司 用於治療子宮外孕的交變電場
CN113373198A (zh) * 2021-06-17 2021-09-10 上海睿钰生物科技有限公司 一种确定细胞的迁移能力的方法和系统
CR20240027A (es) * 2021-06-22 2024-05-28 Lifebridge Innovations Pbc Aparato y método para mejorar la terapia de campo eléctrico para reducir tumores sólidos
MX2023014225A (es) 2021-06-30 2024-01-24 Novocure Gmbh Uso de condensadores para regular la corriente en matrices de transductores para aplicar campos de tratamiento de tumores (ttfields).
US20230001221A1 (en) * 2021-06-30 2023-01-05 Novocure Gmbh Methods of Treating Cancer with Alternating Electric Fields, Checkpoint Inhibitors, and Combination Chemotherapy
EP4408516A1 (en) * 2021-09-30 2024-08-07 Novocure GmbH Reducing electrosensation whilst treating a subject using alternating electric fields
IL312074A (en) 2021-12-14 2024-06-01 Novocure Gmbh Moving a transducer array to reduce skin irritation
CN121371475B (zh) * 2021-12-22 2026-07-17 江苏海莱新创医疗科技有限公司 胶质瘤治疗系统
CN121422385B (zh) * 2021-12-22 2026-07-17 江苏海莱新创医疗科技有限公司 肝癌治疗系统
TW202333820A (zh) 2021-12-29 2023-09-01 瑞士商諾沃庫勒有限責任公司 在使用交流電場治療受試者時藉由使用較大陰極和較小陽極來降低電知覺
EP4456971A1 (en) 2021-12-30 2024-11-06 Novocure GmbH Selecting values of parameters for treatment using tumor treating fields (ttfields)
IL314390A (en) * 2022-03-30 2024-09-01 Novocure Gmbh Using interleaved cooling periods to increase the peak intensity of tumor treating fields
EP4464370B1 (en) 2022-03-30 2026-04-29 Novocure GmbH Reducing electrosensation whilst treating a subject using alternating electric fields by pairing transducer arrays together
US20230310854A1 (en) * 2022-03-31 2023-10-05 Novocure Gmbh Alternating electric field waveform for electrosensation reduction
WO2023193012A2 (en) 2022-04-01 2023-10-05 The Board Of Regents Of The University Of Texas System Methods and apparatus for applying tumor treating fields combined with personalized ultra-fractionated stereotactic adaptive radiotherapy
TW202417078A (zh) 2022-06-30 2024-05-01 瑞士商諾沃庫勒有限責任公司 用於施加腫瘤治療電場的包括多個熱連接但電隔離的石墨片之電極組裝件
TW202430241A (zh) 2022-09-30 2024-08-01 瑞士商諾沃庫勒有限責任公司 在使用交流電場治療受試者時藉由控制上升特性來降低電知覺
US20260108733A1 (en) * 2022-10-25 2026-04-23 Fieldcure Co., Ltd. System and method for electric field transmission
KR102853607B1 (ko) * 2022-10-25 2025-09-03 주식회사 필드큐어 전기장 전달 시스템 및 방법
US12649061B2 (en) 2022-12-29 2026-06-09 Novocure Gmbh Reducing electrosensation during application of alternating electric fields by ensuring that successive increases in amplitude occur during opposite phases of an AC waveform
US12268863B2 (en) 2023-02-06 2025-04-08 Novocure Gmbh Shiftable transducer array with anisotropic material layer
GB2631521A (en) * 2023-07-05 2025-01-08 Qv Bioelectronics Ltd Electric field therapy
US12558538B2 (en) 2023-09-29 2026-02-24 Novocure Gmbh Using staggered changes in amplitude and frequency to ameliorate electrosensation during treatment with alternating electric fields
US20260083819A1 (en) * 2024-09-20 2026-03-26 Novocure Gmbh Compositions, systems, and methods for treating cancer using tumor treating fields (ttfields) and interferon gamma

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5873849A (en) 1997-04-24 1999-02-23 Ichor Medical Systems, Inc. Electrodes and electrode arrays for generating electroporation inducing electrical fields
US6326177B1 (en) * 1999-08-04 2001-12-04 Eastern Virginia Medical School Of The Medical College Of Hampton Roads Method and apparatus for intracellular electro-manipulation
US7136699B2 (en) 2002-10-02 2006-11-14 Standen, Ltd. Apparatus for destroying dividing cells
US7599746B2 (en) 2000-02-17 2009-10-06 Standen Ltd Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases
US8175698B2 (en) 2000-02-17 2012-05-08 Novocure Ltd. Treating bacteria with electric fields
US7890183B2 (en) 2000-02-17 2011-02-15 Novocure Ltd. Treating parasites with electric fields
US7089054B2 (en) 2002-10-02 2006-08-08 Standen Ltd. Apparatus and method for treating a tumor or the like
US6868289B2 (en) 2002-10-02 2005-03-15 Standen Ltd. Apparatus for treating a tumor or the like and articles incorporating the apparatus for treatment of the tumor
US7016725B2 (en) * 2001-11-06 2006-03-21 Standen Ltd. Method and apparatus for destroying dividing cells
US8447395B2 (en) 2000-02-17 2013-05-21 Novocure Ltd Treating bacteria with electric fields
EP2335776A1 (en) 2000-02-17 2011-06-22 Yoram Palti Method and apparatus for destroying dividing cells
US6546290B1 (en) 2000-04-12 2003-04-08 Roamitron Holding S.A. Method and apparatus for electromedical therapy
US6904322B2 (en) 2002-02-15 2005-06-07 Kalaco Scientific, Inc. Transcranial electrostimulation apparatus and method
WO2005115535A2 (en) 2004-04-23 2005-12-08 Novocure Ltd. Treating a tumor or the like with electric fields at different frequencies
DK1833552T3 (da) 2004-12-07 2010-08-02 Standen Ltd Elektroder til anbringelse af et elektrisk felt in-vivo i en længere tidsperiode
CN102488967B (zh) 2004-12-27 2016-03-30 诺沃库勒有限公司 利用电场从不同方向治疗肿瘤等
US20060173493A1 (en) 2005-01-28 2006-08-03 Cyberonics, Inc. Multi-phasic signal for stimulation by an implantable device
DK3804809T3 (da) * 2005-10-03 2024-02-12 Novocure Gmbh Optimering af egenskaberne af et elektrisk felt for at øge feltets effekt på proliferende celler
US8019414B2 (en) * 2006-04-05 2011-09-13 Novocure Ltd. Treating cancer using electromagnetic fields in combination with other treatment regimens
DK2167194T3 (en) 2007-03-06 2017-06-19 Novocure Ltd TREATMENT OF CANCER USING ELECTROMAGNETIC FIELDS IN COMBINATION WITH PHOTODYNAMIC THERAPY
US8715203B2 (en) 2007-09-17 2014-05-06 Novocure Limited Composite electrode
US9655669B2 (en) 2013-05-06 2017-05-23 Novocure Limited Optimizing treatment using TTFields by changing the frequency during the course of long term tumor treatment
US10779875B2 (en) 2013-05-06 2020-09-22 Novocure Gmbh Optimizing treatment using TTfields by changing the frequency during the course of long term tumor treatment
US20190117963A1 (en) 2014-07-25 2019-04-25 Loyalty Based Innovations, LLC Apparatus and method for treating multiple tumors in patients with metastatic disease by electric fields
US9833617B2 (en) * 2014-07-25 2017-12-05 Loyalty Based Innovations, LLC Apparatus and method for treating multiple tumors in patients with metastatic disease by electric fields
US10188851B2 (en) 2015-10-28 2019-01-29 Novocure Limited TTField treatment with optimization of electrode positions on the head based on MRI-based conductivity measurements
US10821283B2 (en) 2016-04-04 2020-11-03 Novocure Gmbh Reducing motility of cancer cells using tumor treating fields (TTFields)
EP3478360B1 (en) 2016-06-30 2024-04-10 Novocure GmbH Arrays for longitudinal delivery of ttfields to a body
CA2972699A1 (en) 2016-07-10 2018-01-10 Novocure Limited Synchronizing tumor cells to the g2/m phase using ttfields combined with taxane or other anti-microtubule agents
CN116747438A (zh) 2016-08-18 2023-09-15 诺沃库勒有限责任公司 用于递送肿瘤治疗电场的阵列中的温度测量
EP3554631B1 (en) 2016-12-13 2022-03-23 Novocure GmbH Treating patients with ttfields with the electrode positions optimized using deformable templates
EP3571503B1 (en) 2017-01-19 2026-04-15 Novocure GmbH System for viewing cell cultures under a microscope whilst applying ttfields
CN112566665A (zh) 2018-04-09 2021-03-26 莫舍·吉拉迪 用TTFields和Aurora激酶抑制剂治疗肿瘤
US11650277B2 (en) 2018-04-10 2023-05-16 Novocure Gmbh TTField treatment with optimization of electrode positions based on low frequency (<1MHZ) AC conductivity estimates derived from two MRI images having different repetition times
KR102870236B1 (ko) 2018-07-03 2025-10-14 에드윈 창 세포막 투과성을 향상시키기 위한 교류 전기장 사용
US11179322B2 (en) 2018-07-10 2021-11-23 Novocure Gmbh Methods and compositions for treating tumors with TTFields and sorafenib
IL279253B2 (en) 2018-07-18 2025-09-01 Novocure Gmbh Using power loss density and related measurements to quantify dose of tumor treatment fields
MX2020013519A (es) 2018-08-23 2021-05-12 Novocure Gmbh Uso de campos electricos alternativos para aumentar la permeabilidad de la barrera hematoencefalica.
US11160977B2 (en) 2018-09-04 2021-11-02 Novocure Gmbh Delivering tumor treating fields (TTFields) to the infratentorial brain
US11020585B2 (en) 2018-09-07 2021-06-01 Novocure Gmbh Treating autoimmune diseases using an alternating electric field to reduce the proliferation of t-cells
US20200108031A1 (en) 2018-10-05 2020-04-09 Novocure Gmbh Treating Tumors Using TTFields Combined with ABT-751
CN113164525B (zh) 2018-10-23 2025-03-14 利兰·斯坦福青年大学托管委员会 在基于干细胞的疗法中使用交变电场预防和治疗畸胎瘤形成
CN112955208B (zh) 2018-10-25 2024-11-22 诺沃库勒有限责任公司 向受试者的脊柱解剖结构递送交变电场(例如，ttfields)的方法
US20200146586A1 (en) 2018-11-14 2020-05-14 Novocure Gmbh Creating Accurate Computational Head Models of Patients Using Datasets Combining MRI and CT Images
HUE065574T2 (hu) 2018-11-19 2024-06-28 Novocure Gmbh Tömbök daganatkezelõ mezõk (TTFIELD) rendelkezésre bocsátására szelektíven címezhetõ alelemekkel
JP7353363B2 (ja) 2018-11-29 2023-09-29 ノボキュア ゲーエムベーハー ＴＴＦｉｅｌｄｓ（腫瘍治療電場）を提供するための柔軟性を高めたトランスデューサーアレイ
EP3968279B1 (en) 2019-01-08 2025-01-01 Novocure GmbH Evaluating quality of segmentation of an image into different types of tissue for planning treatment using tumor treating fields (ttfields)
EP3939568A1 (en) 2019-02-22 2022-01-19 Novocure GmbH Treating gastric cancer using ttfields and drug in combination
WO2020174403A1 (en) 2019-02-26 2020-09-03 Moshe Giladi Determining a frequency for ttfields treatment based on an electrical characteristic of targeted cancer cells
EP4491214B1 (en) 2019-02-27 2026-01-21 Novocure GmbH Delivering tumor treating fields (ttfields) using implantable transducer arrays
PL3946322T3 (pl) 2019-03-29 2024-02-26 Novocure Gmbh Sposoby przywracania wrażliwości na ttfields w komórkach nowotworowych opornych wobec ttfields, z inhibitorami ptger3
WO2020212824A1 (en) 2019-04-17 2020-10-22 Yoram Wasserman Uploading data from an isolated system without compromising isolation

Also Published As

Publication number Publication date
PT3439733T (pt) 2020-03-25
EP3693054B1 (en) 2023-06-28
WO2017175116A1 (en) 2017-10-12
JP7171827B2 (ja) 2022-11-15
US20210008367A1 (en) 2021-01-14
JP2019510606A (ja) 2019-04-18
PL3439733T3 (pl) 2020-07-27
JP2021126552A (ja) 2021-09-02
CN116549848A (zh) 2023-08-08
KR102430229B1 (ko) 2022-08-05
DK3439733T3 (da) 2020-03-23
EP3439733B1 (en) 2019-12-25
EP3693054A3 (en) 2020-10-28
US10821283B2 (en) 2020-11-03
CN109475735B (zh) 2023-05-23
EP3693054C0 (en) 2023-06-28
EP3693054A2 (en) 2020-08-12
CN109475735A (zh) 2019-03-15
EP4234005B1 (en) 2026-07-15
HUE048646T2 (hu) 2020-08-28
EP3439733A1 (en) 2019-02-13
US11191956B2 (en) 2021-12-07
US20170281934A1 (en) 2017-10-05
EP4234005A2 (en) 2023-08-30
JP6896839B2 (ja) 2021-06-30
KR20180133431A (ko) 2018-12-14
EP4234005A3 (en) 2024-01-10
CA3019474A1 (en) 2017-10-12

Similar Documents

Publication Publication Date Title
JP7171827B2 (ja) 腫瘍治療電場（ＴＴＦｉｅｌｄｓ）を使用してがん細胞の運動性を低下させる
BR112020025692A2 (pt) Inibição de infecção viral usando campos elétricos alternados
Prince et al. The impact of sleep loss on hippocampal function
Tang et al. FGF2 attenuates neural cell death via suppressing autophagy after rat mild traumatic brain injury
Crosby et al. Early afferent activity from the facet joint after painful trauma to its capsule potentiates neuronal excitability and glutamate signaling in the spinal cord
Zhen et al. Wip1 regulates blood-brain barrier function and neuro-inflammation induced by lipopolysaccharide via the sonic hedgehog signaling signaling pathway
Rochfort et al. Thrombomodulin regulation in human brain microvascular endothelial cells in vitro: role of cytokines and shear stress
Weishaupt et al. Vector-induced NT-3 expression in rats promotes collateral growth of injured corticospinal tract axons far rostral to a spinal cord injury
EP4253392A4 (en) CHEMOTHERAPEUTIC PRODRUG OF PT(IV) AND CONTROLLED RELEASE THEREOF FOR THE TREATMENT OF TUMORS
Zeng et al. TMEM16A regulates portal vein smooth muscle cell proliferation in portal hypertension
Yang et al. The role of microtubule-associated protein 1B in axonal growth and neuronal migration in the central nervous system
Lee et al. Nutlin-3 induces BCL2A1 expression by activating ELK1 through the mitochondrial p53-ROS-ERK1/2 pathway
Xiao et al. Transcranial direct current stimulation relieves visceral hypersensitivity via normalizing GluN2B expression and neural activity in anterior cingulate cortex
Li et al. The neuroprotective mechanism of spinal cord stimulation in spinal cord ischemia/reperfusion injury
Jiang et al. Update of recent studies of adenomyosis-associated dysmenorrhea
US20220387811A1 (en) Medical device and method for generating a plasma-activated liquid
Wang et al. Methylprednisolone inhibits the proliferation and affects the differentiation of rat spinal cord-derived neural progenitor cells cultured in low oxygen conditions by inhibiting HIF-1α and Hes1 in vitro
HK40098373A (en) Reducing motility of cancer cells using tumor treating fields (ttfields)
HK40023684B (en) Reducing motility of cancer cells using tumor treating fields (ttfields)
HK40023684A (en) Reducing motility of cancer cells using tumor treating fields (ttfields)
HK1260435A1 (en) Reducing motility of cancer cells using tumor treating fields (ttfields)
HK1260435B (en) Reducing motility of cancer cells using tumor treating fields (ttfields)
Zhang et al. Combined application of Rho-ROCKII and GSK-3β inhibitors exerts an improved protective effect on axonal regeneration in rats with spinal cord injury
Aliev et al. The three-vessel occlusion as a model of vascular dementia–oxidative stress and mitochondrial failure as an indicator of brain hypoperfusion
Hao et al. Sigma-1 receptor activation ameliorates age-related postoperative cognitive dysfunction by attenuating endoplasmic reticulum stress and neuroinflammation